MNLO - Menlo Therapeutics drops 17% after pricing equity offering June, 05 2020 07:13 AM VYNE Therapeutics Menlo Therapeutics (NASDAQ:MNLO) has priced its public offering of ~27.1M common shares at $1.85/share, for expected gross proceeds of $50,042,500.More news on: Menlo Therapeutics Inc., Healthcare stocks news, , Stocks on the move, Read more ...